Companies: 10,795·Total market cap: $144.5T
Bausch Health Companies Inc.

Bausch Health Companies Inc.

BHCNYSEHealthcare● Active
$5.37
+$0.11(+2.09%)
Market Cap$2.0B
P/E Ratio
52W High$8.69
52W Low$4.61

Bausch Health Companies Inc. (BHC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

bhc · stock forecast · 38 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 38 Wall Street analysts in the past 3 months

SellBuy

Buy

38 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
19
Hold
15
Sell
4
Strong Sell
0
Total: 38 · Buy rate: 50.0%

12-Month Price Target

High

$8.00

Consensus

$8.00

+49.0% upside

Low

$8.00

Median: $8 · Last Close: $5.37

The Bausch Health Companies Inc. (BHC) analyst consensus is Buy, based on ratings from 38 Wall Street analysts over the past 3 months. The average 12-month BHC price target is $8.00, representing +49.0% upside from the current price of $5.37.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Analyst price target coverage is insufficient to generate a forecast chart for this stock.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$5.242.35%

1-day model range: $5.22–$5.27. Peak: $5.27 (-2.35%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4-19.7%
2028$4-29.3%
2029$4-34.3%
2030$3-37.1%
2031-38.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%
6Buy
1Neutral
7Sell
RSI (14)48.1Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · BHC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$5.18BUY
MA 10$5.29BUY
MA 20$5.36BUY
MA 50$5.48SELL
MA 100$5.66SELL
MA 200$6.22SELL
Current $BHC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.25BUY
EMA 10$5.28BUY
EMA 20$5.35BUY
EMA 50$5.48SELL
EMA 100$5.69SELL
EMA 200$5.99SELL
Current $BHC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
RBC Capital2026-04-27
Maintains
Sector PerformSector Perform
Barclays2026-02-25
Maintains
Equal WeightEqual Weight
Truist Securities2026-01-07
Maintains
HoldHold
RBC Capital2025-05-02
Maintains
Sector PerformSector Perform
Jefferies2025-02-06
Downgrade ↓
BuyHold
RBC Capital2025-01-30
Maintains
Sector PerformSector Perform
RBC Capital2024-11-01
Maintains
Sector PerformSector Perform
Piper Sandler2024-08-02
Downgrade ↓
NeutralUnderweight
RBC Capital2024-08-02
Maintains
Sector PerformSector Perform
Truist Securities2024-07-25
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on Bausch Health Companies Inc. (BHC) stock. Of the recent 194 rating actions, 23 were upgrades and 28 were downgrades. 38 analysts currently cover BHC.

Analyst Recommendation Trends

Buy ratings00
Hold ratings11
Sell ratings00

BHC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$10.5B

↑ 9.3% YoY

Revenue Next Year

$10.5B

↓ 0.0% YoY

EPS This Year

$4.30

EPS Next Year

$4.14

↓ 3.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BHC EPS of $4.30 for the current fiscal year, based on estimates from 4 analysts. The BHC revenue forecast is $10.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BHC stock forecast is supported by two independent data sources: analyst consensus ratings from 38 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BHC price target is $8.00 (+49.0% upside), with an analyst consensus of Buy.

The BHC short-term stock prediction for tomorrow is $5.24 (-2.35%). The BHC stock price prediction for 2027 estimates an average of $4. The BHC stock prediction for 2030 projects a range of $3–$4.

Bausch Health Companies Inc. trades on NYSE under the ticker BHC. The BHC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BHC forecast · 8 questions

According to 38 Wall Street analysts, the average 12-month BHC price target is $8.00, with a high forecast of $8.00 and a low of $8.00. The median price target is shown in the chart above when available. This implies +49.0% potential upside from the current price of $5.37.

BHC price targetWhat is BHC price targetBHC analyst price targetBHC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.